- Home
- SSP vs CRVO Comparison
SSP vs CRVO Comparison
Compare SSP & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSP | CRVO |
|---|---|---|
| Founded | 1878 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.2M | 78.5M |
| IPO Year | 1988 | N/A |
Fundamental Metrics
Financial Performance| Metric | SSP | CRVO |
|---|---|---|
| Price | $3.97 | $7.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $5.50 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 982.4K | 55.4K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,318,706,000.00 | $6,159,786.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.11 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.36 | $1.92 |
| 52 Week High | $4.98 | $16.94 |
Technical Indicators
Market Signals| Indicator | SSP | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 46.56 | 45.09 |
| Support Level | $3.88 | $7.60 |
| Resistance Level | $4.98 | $8.46 |
| Average True Range (ATR) | 0.30 | 0.53 |
| MACD | -0.14 | -0.07 |
| Stochastic Oscillator | 12.36 | 38.78 |
Price Performance
Historical ComparisonAbout SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.